Value-Added Medicines in 2025: Industry Trends and Strategic Partnerships, A Q&A with James Burt, CEO of Pharmanovia
In this interview, we sat down with James Burt, CEO of Pharmanovia, to reflect on industry trends from 2024...
Innocare Announces BCL2 Inhibitor & Orelabrutinib for CLL/SLL
InnoCare Pharma received approval from China’s CDE to begin a Phase III trial of its BCL2 inhibitor, ICP-248 (Mesutoclax),...
GSK’s PENMENVY Vaccine Approved by US FDA
The FDA approved GSK’s PENMENVY, a combination vaccine against five serogroups of meningococcal disease (A, B, C, W, and...
Revolutionary New Prostate Cancer Super Test Developed in UK
Scientists in Cambridge developed a new prostate cancer test designed to revolutionize screening, diagnosis, and personalized treatment. The test...
Lacutamab Gets FDA Breakthrough Therapy for Sézary Syndrome
Innate Pharma received Breakthrough Therapy Designation from the FDA for lacutamab, its anti-KIR3DL2 antibody, for treating relapsed or refractory...
Carmat Aeson® Artificial Heart Shows Promise for Pulmonary Hypertension Patients
A single-center study at the University Medical Center of Astana, Kazakhstan, demonstrated the effectiveness of the Aeson® total artificial...
Dupixent® FDA Priority Review for Bullous Pemphigoid Treatment
Regeneron and Sanofi announced that the FDA accepted for Priority Review their supplemental Biologics License Application for Dupixent (dupilumab)...
ICON Discusses How AI is Changing Clinical Trial Recruitment and Diversity
In this discussion with Kathleen Mandziuk, Vice President of eClinical Development & Delivery at ICON, we explore the dynamic...
Where is RBQM Heading in The Future With AI?
Richard Young, Chief Strategy Officer at CluePoints, shares insights on AI and risk-based quality management (RBQM) in clinical trials....
EU Approves First Self-Amplifying mRNA COVID-19 Vaccine
CSL and Arcturus Therapeutics announced that the European Commission has approved KOSTAIVE (ARCT-154), a self-amplifying mRNA COVID-19 vaccine, for...